申请人:Marsilje Thomas
公开号:US20080194668A1
公开(公告)日:2008-08-14
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TPO activity, particularly diseases or disorders that involve thrombocytopenia.
这项发明提供了一类新型化合物,包括这些化合物的药物组合物以及使用这些化合物治疗或预防与异常或失调的TPO活性相关的疾病或疾病的方法,特别是涉及血小板减少症的疾病或疾病。